Woodley Farra Manion Portfolio Management Inc Ionis Pharmaceuticals Inc Transaction History

Woodley Farra Manion Portfolio Management Inc

  • $1.83 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 05, 2020
SELL
$47.45 - $62.95 $56,940 - $75,540
-1,200 Closed
0 $0
Q2 2020

Aug 12, 2020
SELL
$46.85 - $61.05 $143,688 - $187,240
-3,067 Reduced 71.88%
1,200 $71,000
Q4 2019

Feb 14, 2020
BUY
$53.85 - $65.27 $10,770 - $13,054
200 Added 4.92%
4,267 $258,000
Q2 2019

Aug 12, 2019
SELL
$62.09 - $86.14 $5,463 - $7,580
-88 Reduced 2.12%
4,067 $261,000
Q1 2019

May 14, 2019
BUY
$52.92 - $81.17 $219,882 - $337,261
4,155 New
4,155 $337,000

Others Institutions Holding IONS

# of Institutions
390
Shares Held
125M
Call Options Held
2.25M
Put Options Held
510K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.5B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Woodley Farra Manion Portfolio Management Inc Portfolio

Follow Woodley Farra Manion Portfolio Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodley Farra Manion Portfolio Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Woodley Farra Manion Portfolio Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email